99 related articles for article (PubMed ID: 8561350)
1. Intrathecal bleeding after the intraoperative use of heparin and urokinase during continuous spinal anesthesia.
Rabito SF; Ahmed S; Feinstein L; Winnie AP
Anesth Analg; 1996 Feb; 82(2):409-11. PubMed ID: 8561350
[No Abstract] [Full Text] [Related]
2. Acute management of intracranial hemorrhage in patients receiving thrombolytic therapy: case reports.
Eleff SM; Borel C; Bell WR; Long DM
Neurosurgery; 1990 May; 26(5):867-9. PubMed ID: 2352604
[TBL] [Abstract][Full Text] [Related]
3. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
Usui M; Saito N; Hoya K; Todo T
Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
[TBL] [Abstract][Full Text] [Related]
4. Epidural hematoma associated with epidural anesthesia: complications of anticoagulant therapy.
Onishchuk JL; Carlsson C
Anesthesiology; 1992 Dec; 77(6):1221-3. PubMed ID: 1466472
[No Abstract] [Full Text] [Related]
5. A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Moia M; Mannucci PM; Pini M; Prandoni P; Gurewich V
Thromb Haemost; 1994 Sep; 72(3):430-3. PubMed ID: 7531876
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of urokinase and heparin on PTT values during thrombolytic therapy.
Sheiman RG; Phillips DA
Angiology; 1993 Feb; 44(2):114-22. PubMed ID: 8434804
[TBL] [Abstract][Full Text] [Related]
7. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
Motomiya T
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
[No Abstract] [Full Text] [Related]
8. [Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
Chiche P; Bénaim R; Samama M; Maury J
Coeur Med Interne; 1978; 17(1):59-66. PubMed ID: 639489
[No Abstract] [Full Text] [Related]
9. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
Ouriel K; Kandarpa K
J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
[TBL] [Abstract][Full Text] [Related]
10. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
[TBL] [Abstract][Full Text] [Related]
11. [An allergic reaction due to i.v. urokinase administration].
Mastrogiuseppe G; Tullio D
Minerva Cardioangiol; 1994 Oct; 42(10):507-8. PubMed ID: 7816241
[TBL] [Abstract][Full Text] [Related]
12. Urokinase in thromboembolic disease: Pulmonary embolism.
Sasahara AA; Stengle JM; Sherry S
Am Heart J; 1975 Mar; 89(3):403-4. PubMed ID: 1090139
[No Abstract] [Full Text] [Related]
13. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis in neonates.
Collin M
Clin Pediatr (Phila); 2001 Feb; 40(2):109-10. PubMed ID: 11261447
[No Abstract] [Full Text] [Related]
15. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
Kajimoto Y; Ohta T; Kuroiwa T
Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
[TBL] [Abstract][Full Text] [Related]
16. Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator.
Cinà CS; Goh RH; Chan J; Kenny B; Evans G; Rawlinson J; Gill G
Ann Vasc Surg; 1999 Nov; 13(6):571-5. PubMed ID: 10541608
[TBL] [Abstract][Full Text] [Related]
17. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
Mikkola KM; Patel SR; Parker JA; Grodstein F; Goldhaber SZ
Am Heart J; 1997 Jul; 134(1):69-72. PubMed ID: 9266785
[TBL] [Abstract][Full Text] [Related]
18. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis.
van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F
Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570
[TBL] [Abstract][Full Text] [Related]
19. Spinal epidural hematoma associated with epidural anesthesia: complications of systemic heparinization in patients receiving peripheral vascular thrombolytic therapy.
Dickman CA; Shedd SA; Spetzler RF; Shetter AG; Sonntag VK
Anesthesiology; 1990 May; 72(5):947-50. PubMed ID: 2339809
[No Abstract] [Full Text] [Related]
20. High-dose urokinase therapy in newborn infants with major vessel thrombosis.
Giacoia GP
Clin Pediatr (Phila); 1993 Apr; 32(4):231-7. PubMed ID: 8462236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
